J2770 – Injection, quinupristin/dalfopristin, 500 mg (150/350)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2770
- Long description
- Injection, quinupristin/dalfopristin, 500 mg (150/350)
- Short description
- Quinupristin/dalfopristin
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2001
- Last change
- January 1, 2001 – No change
Frequently asked questions
What is HCPCS code J2770?
J2770 is a HCPCS Level II code for injection, quinupristin/dalfopristin, 500 mg (150/350).
Does Medicare cover J2770?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2710 – Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711 – Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720 – Injection, protamine sulfate, per 10 mg
- J2724 – Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 – Injection, protirelin, per 250 mcg
- J2730 – Injection, pralidoxime chloride, up to 1 gm
- J2760 – Injection, phentolamine mesylate, up to 5 mg
- J2765 – Injection, metoclopramide hcl, up to 10 mg
- J2777 – Injection, faricimab-svoa, 0.1 mg
- J2778 – Injection, ranibizumab, 0.1 mg
- J2779 – Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
- J2780 – Injection, ranitidine hydrochloride, 25 mg
- J2781 – Injection, pegcetacoplan, intravitreal, 1 mg
- J2782 – Injection, avacincaptad pegol, 0.1 mg
- J2783 – Injection, rasburicase, 0.5 mg
- J2785 – Injection, regadenoson, 0.1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.